<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0011">
 <label>11.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Davidson</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>McCabe</surname>
    <given-names>TM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Crotta</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment</article-title>. 
  <source>EMBO Mol Med</source>
  <year>2016</year>; 
  <volume>8</volume>:
  <fpage>1099</fpage>–
  <lpage>112</lpage>.
  <pub-id pub-id-type="pmid">27520969</pub-id>
 </mixed-citation>
</ref>
